Studies identify a marker of treatment response for patients with advanced, drug-resistant ovarian cancer.
March 2024. Full story at National Cancer Institute.
Studies identify a marker of treatment response for patients with advanced, drug-resistant ovarian cancer.
March 2024. Full story at National Cancer Institute.